Intracellular enzymatic reducing systems control receptor tyrosine kinase signaling via PTP1B
Science Advances · 2026
DOI: 10.1126/sciadv.adv5362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Lucia Coppo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 1, Signal Transduction, Receptor Protein-Tyrosine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancerfonden, Vetenskapsrådet, Knut and Alice Wallenberg Foundations.
Abstract (Originalsprache)
Protein tyrosine phosphatases (PTPs) counteract receptor tyrosine kinase (RTK) signaling. Inhibition of PTPs by oxidation can be reversed by cytosolic thioredoxin (TXN), but less is known about regulation of PTPs by glutathione (GSH)–driven glutaredoxins (GLRXs). Here, we thus assessed GLRX1, GLRX2, and/or TXN1 in regulation of CO 2 /bicarbonate- and H 2 O 2 -mediated oxidation of the physiologically important PTP1B. GLRXs and TXN1 synergistically maintained PTP1B activity, and modulating cellular levels of either GLRX1, GLRX2, or TXN1 gave strong effects on phosphorylation cascades triggered by epidermal growth factor (EGF) or platelet-derived growth factor (PDGF). Furthermore, transient intracellular interactions of PTP1B with GLRX1, GLRX2, and TXN1 were discovered within minutes after stimuli with either PDGF or EGF, coinciding with control of the corresponding RTK-driven phosphorylation cascades. We conclude that TXN1 and GLRXs are key regulators of PTP1B activity and thus control cellular responses to RTK stimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
- Department of Selenoprotein Research and National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
ORCID-Profile: Lucia Coppo, Qing Cheng, Axel Tobias Scholz, Elias S J Arnér, Markus Dagnell
Förderung
- Cancerfonden
- Vetenskapsrådet
- Knut and Alice Wallenberg Foundations
- Hungarian National Research, Development, and Innovation Office
- Hungarian Thematic Excellence Programme
- Hungarian National Laboratories Program
Zitieren
APA
Coppo, L., Zhao, W., Cheng, Q., Scholz, A. T., Arnér, E. S. J., & Dagnell, M. (2026). Intracellular enzymatic reducing systems control receptor tyrosine kinase signaling via PTP1B. Science Advances. https://doi.org/10.1126/sciadv.adv5362
Vancouver
Coppo L, Zhao W, Cheng Q, Scholz AT, Arnér ESJ, Dagnell M. Intracellular enzymatic reducing systems control receptor tyrosine kinase signaling via PTP1B. Science Advances. 2026. doi:10.1126/sciadv.adv5362
BibTeX
@article{Coppo2026,
author = {Coppo, Lucia and Zhao, Wenchao and Cheng, Qing and Scholz, Axel Tobias and Arnér, Elias S J and Dagnell, Markus},
title = {Intracellular enzymatic reducing systems control receptor tyrosine kinase signaling via PTP1B},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adv5362}
}
EUVIMED